New device uses light and zaps to fight back pain

NCT ID NCT07313826

Not yet recruiting Symptom relief Sponsor: Defense and Veterans Center for Integrative Pain Management Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study will test whether the Neurolumen device—which combines low-level lasers, LEDs, and electrical stimulation—can reduce pain and painkiller use in 50 adults with chronic low back pain. Participants will use the device daily for 4 weeks, and some will receive a sham (inactive) version for comparison. The goal is to see if this FDA-cleared device offers a non-drug way to manage persistent back pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Neurolumen device (low-level lasers, LEDs, and electrical stimulation)
What this could lead to: If it works, this could offer a drug-free option to manage chronic low back pain and reduce reliance on painkillers.
What could go wrong: This is a small pilot study (50 people) with no blinding results yet. The sham device may also provide some relief, making it hard to prove real benefit. Long-term effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LOW-BACK PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Pain Low Back Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC LOW-BACK PAIN

Contacts and locations

Locations

Naval Medical Center Portsmouth

Portsmouth, Virginia, 23708, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.